Curcumin enhances anti‑cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells

• Published in: Oncology reports Vol. 44; no. 4; pp. 1393 - 1402
• Main Authors: Liu, Pan, Ying, Qian, Liu, Huan, Yu, Si-Qi, Bu, Lu-Ping, Shao, Liang, Li, Xin-Yi
• Format: Journal Article
• Language: English
• Published: Athens Spandidos Publications 01.10.2020; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Antibodies; Apoptosis; Cancer metastasis; Cancer research; Cancer therapies; Cancer treatment; Cell adhesion & migration; Cell growth; Drug dosages; Drug therapy; Medical prognosis; Metastasis; Microscopy; Pancreatic cancer; Transmission electron microscopes; Wound healing; China

Curcumin is a natural compound extracted from turmeric (Curcuma longa), which has been reported to be a promising anti-cancer drug in various human cancers. However, the effects of combination treatment of curcumin with gemcitabine or docetaxel on pancreatic cancer remains elusive. In the present st...